Ezetimibe 10 mg
Sponsors
Organon and Co, Bronx VA Medical Center, JW Pharmaceutical, Punjab Institute of Cardology
Conditions
Acute Coronary Syndromes (ACS)Coronary DiseaseDiabetes Mellitus, Type 2Hypercholesterolemia
Phase 3
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
CompletedNCT00423488
Start: 2005-07-12End: 2007-02-16Updated: 2022-02-09
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
CompletedNCT01154036
Start: 2010-07-31End: 2012-10-31Updated: 2022-02-09
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
CompletedNCT02550288
Start: 2015-09-29End: 2016-05-30Updated: 2024-05-16
A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)
CompletedNCT02741245
Start: 2016-06-09End: 2017-01-18Updated: 2024-05-16
An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
CompletedNCT03867110
Start: 2000-03-06End: 2001-07-27Updated: 2024-05-10
Phase 4
Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
Active, not recruitingNCT07442630
Start: 2023-08-21End: 2026-11-30Updated: 2026-03-02
Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome
Not yet recruitingNCT07508254
Start: 2026-05-01End: 2026-10-31Target: 120Updated: 2026-04-02